Answers are grounded in this paper and cite their sources.
This analysis identifies novel SUPT5H variants affecting β-thalassemia traits in different families, underscoring genetic regulation implications.
β-Thalassemia is a common genetic hematological disorder resulting from absent or reduced expression of the β-globin gene (HBB). Beyond defects in HBB itself, defects in genes involving its regulation, such as KLF1, ERCC2, and SUPT5H can cause β-thalassemia-like phenotypes. Here, we identified two novel variants in the SUPT5H gene in two families. Family 1 carried a splice-site variant (c.967-1G > A), while family 2 harbored a frameshift variant (c.2605delC, p.Q869Rfs*85). The hematological profiles of all carriers of SUPT5H variants are consistent with previously reported heterozygous SUPT5H-related traits, underscoring the role of SUPT5H haploinsufficiency in modulating HBB regulation.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: